Overexpression of p53 and HER-2/neu Proteins as Prognostic Markers in Early Stage Breast Cancer
Jeffrey R. Marks(Duke Medical Center), J. Dirk Iglehart(Brigham and Women's Hospital), Katherine Wu(New York University), Billie‐Jo M. Kerns(Duke Medical Center), Nicholas Bandarenko(Duke Medical Center), Donald A. Berry(Berry & Associates (United States)), Peter A. Humphrey(Jewish Hospital)
Cited by 112
Related Papers
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818
A Python library for probabilistic analysis of single-cell omics data
|Nature Biotechnology|2022|815